Упрощенная HTML-версия
kappaB / M. Biermer, R. Puro, R.J. Schneider // J. Virol. - 2003. - Vol.77,№7. – Р.
4033-4042.
118.
Bile duct changes in rats reinfected with Clonorchis sinensis /
D. Choi, S.T. Hong, S. Li et al. // Korean. J. Parasitol. - 2004. - Vol.42,№1. - Р.7-
17.
119.
Blood neutrophil functions and cytokine release in severe alcoholic hepatitis:
effect of corticosteroids / J. Taieb, P. Mathurin, C. Elbim et al. // J. Hepatol. -
2000. -Vol.32,№4. - Р. 579-586.
120.
Carreno V. Biological properties of interleukin-12 and its therapeutic use in
persistent hepatitis B virus and hepatitis C virus infection / V. Carreno,
J.A.Quiroga // J. Viral. Hepat. - 1997. - Suppl 2. - P. 83-86.
121.
Cavanaugh V.J. Interleukin-12 inhibits hepatitis B virus replication in
transgenic mice / V.J. Cavanaugh, L.G. Guidotti, F.V. Chisari // J. Virol. - 1997. -
Vol.71,№4. - Р. 3236-3243.
122.
Cellular and humoral immune responses induced by intradermal or
intramuscular vaccination with the major hepatitis B surface antigen / F. Rahman,
A. Dahmen. S. Herzog-Hauff et al. // Hepatology. - 2000. - Vol.
31. - P.
521-527.
123.
Characterization of self-reactive T cells that evade tolerance in hepatitis B e
antigen transgenic mice / D.R. Milich, F. Schodel, D.L. Peterson et al. // Eur. J.
Immunol. - 1995. - Vol.
25. - P.
1663-1672.
124.
Chemok
in
e-chemok
in
e receptor
in
teractions provide a mechanism for the
selective recruitment of Th1 lymphocytes
in
to
hepatitis
C
in
fected liver / P.L.
Shields, M. Salmon, S.G. Hubscher et al. // Hepatology. - 1998. - Vol.28. - P.
465.
125.
Chisari F.V. Hepatitis B virus immunopathogenesis / F.V. Chisari, C. Ferrari //
Annu. Rev. Immunol. - 1995.- Vol.
13. - P.
29-45.